Community Academic Profiles–

Jonathan S. Berek

Back to Profile

Publication Details

  • Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.

    McGuire WP, Hoskins WJ, Brady MF, Homesley HD, Creasman WT, Berman ML, Ball H, Berek JS, Woodward J. J Clin Oncol. 1995; 13 (7): 1589-99

    We report a prospective randomized trial in women with advanced ovarian cancer to evaluate the importance of chemotherapy dose-intensity on survival, progression-free survival (PFS), and response.

    PubMedID: 7602348

Stanford Medicine Resources:

Footer Links: